Martin Makary

arrow back backwards u-turn turn around reverse
Pharma

Hims quits on obesity pill after legal, regulatory heat

Hims has quickly retreated from its launch of a compounded obesity pill after facing mounting pressure from the FDA and Novo Nordisk.
Fraiser Kansteiner Feb 9, 2026 10:24am
Makary

FDA commissioner pledges crackdown on compounding practices

Feb 6, 2026 9:59am
FDA

FDA launches PreCheck program to ease US drug plant build-outs

Feb 2, 2026 10:27am
speedy fast accelerated review accelerated approval racetrack race track quick

USAntibiotics scores first FDA national priority voucher nod

Dec 10, 2025 2:30pm
FDA
Favicon Fierce Biotech

FDA names Tracy Beth Høeg as acting head of drug center

Dec 4, 2025 4:03am
Makary
Favicon Fierce Biotech

2 lawmakers push for answers as questions swirl over FDA program

Nov 25, 2025 10:30am